213 related articles for article (PubMed ID: 25729686)
1. Insulin-like growth factor- I and factors affecting it in thalassemia major.
Soliman AT; De Sanctis V; Elalaily R; Yassin M
Indian J Endocrinol Metab; 2015; 19(2):245-51. PubMed ID: 25729686
[TBL] [Abstract][Full Text] [Related]
2. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
Soliman AT; Yassin MA; De Sanctis V
Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone - insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.
Soliman A; De Sanctis V; Yassin M; Abdelrahman MO
Indian J Endocrinol Metab; 2014 Jan; 18(1):32-8. PubMed ID: 24701427
[TBL] [Abstract][Full Text] [Related]
4. New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.
Carsote M; Vasiliu C; Trandafir AI; Albu SE; Dumitrascu MC; Popa A; Mehedintu C; Petca RC; Petca A; Sandru F
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010271
[TBL] [Abstract][Full Text] [Related]
5. Age related IGF-I changes and IGF-I generation in thalassemia major.
Soliman AT; Abushahin A; Abohezeima K; Khalafallah H; Adel A; Elawwa A; Elmulla N
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():278-83. PubMed ID: 21705978
[TBL] [Abstract][Full Text] [Related]
6. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study.
Soliman AT; elZalabany M; Amer M; Ansari BM
J Trop Pediatr; 1999 Feb; 45(1):23-30. PubMed ID: 10191589
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.
Soliman AT; El Banna N; Abdel Fattah M; ElZalabani MM; Ansari BM
Metabolism; 1998 May; 47(5):541-8. PubMed ID: 9591744
[TBL] [Abstract][Full Text] [Related]
8. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.
Scacchi M; Danesi L; Cattaneo A; Sciortino G; Radin R; Ambrogio AG; Vitale G; D'Angelo E; Mirra N; Zanaboni L; Arvigo M; Boschetti M; Ferone D; Marzullo P; Baldini M; Cassinerio E; Cappellini MD; Persani L; Cavagnini F
Endocrine; 2016 Aug; 53(2):551-7. PubMed ID: 26825070
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
Moayeri H; Oloomi Z
Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
[TBL] [Abstract][Full Text] [Related]
10. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.
Roth C; Pekrun A; Bartz M; Jarry H; Eber S; Lakomek M; Schröter W
Eur J Pediatr; 1997 Oct; 156(10):777-83. PubMed ID: 9365067
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major.
Soliman AT; Nasr I; Thabet A; Rizk MM; El Matary W
Metabolism; 2005 Jan; 54(1):15-23. PubMed ID: 15562375
[TBL] [Abstract][Full Text] [Related]
12. Basal and stimulated levels of growth hormone, insulin-like growth factor-I (IGF-I), IGF-I binding and IGF-binding proteins in beta-thalassemia major.
Karydis I; Karagiorga-Lagana M; Nounopoulos C; Tolis G
J Pediatr Endocrinol Metab; 2004 Jan; 17(1):17-25. PubMed ID: 14960017
[TBL] [Abstract][Full Text] [Related]
13. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of blood transfusion on growth hormone and insulin-like growth factor-1 levels in children with thalassemia.
Mahachoklertwattana P; Yimsumruay T; Poomthavorn P; Chuansumrit A; Khlairit P
Horm Res Paediatr; 2011; 75(4):240-5. PubMed ID: 21051865
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong.
Kwan EY; Lee AC; Li AM; Tam SC; Chan CF; Lau YL; Low LC
J Paediatr Child Health; 1995 Apr; 31(2):83-7. PubMed ID: 7794630
[TBL] [Abstract][Full Text] [Related]
16. The multifactorial origin of growth failure in thalassaemia.
Skordis N; Kyriakou A
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():271-7. PubMed ID: 21705977
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of growth hormone deficiency in adult polytransfused β-thalassemia patients and correlation with transfusional and chelation parameters.
Poggi M; Pascucci C; Monti S; Pugliese P; Lauri C; Amodeo G; Girelli G; Toscano V
J Endocrinol Invest; 2010 Sep; 33(8):534-8. PubMed ID: 20157288
[TBL] [Abstract][Full Text] [Related]
18. Thalassaemia and aberrations of growth and puberty.
Kyriakou A; Skordis N
Mediterr J Hematol Infect Dis; 2009 Jul; 1(1):e2009003. PubMed ID: 21415985
[TBL] [Abstract][Full Text] [Related]
19. Growth and factors affecting it in thalassemia major.
Soliman AT; Khalafallah H; Ashour R
Hemoglobin; 2009; 33 Suppl 1():S116-26. PubMed ID: 20001614
[TBL] [Abstract][Full Text] [Related]
20. Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent.
Cavallo L; Gurrado R; Gallo F; Zacchino C; De Mattia D; Tatò L
Clin Endocrinol (Oxf); 1997 Jun; 46(6):701-6. PubMed ID: 9274700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
